These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11258433)

  • 1. FasL is important in costimulation blockade-resistant skin graft rejection.
    Trambley J; Lin A; Elwood E; Bingaman AW; Lakkis F; Corbascio M; Pearson TC; Larsen CP
    Transplantation; 2001 Feb; 71(4):537-43. PubMed ID: 11258433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
    Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
    Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.
    Wagener ME; Konieczny BT; Dai Z; Ring GH; Lakkis FG
    Transplantation; 2000 Jun; 69(11):2428-32. PubMed ID: 10868653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights in CD28-independent allograft rejection.
    Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
    Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection.
    Vu MD; Amanullah F; Li Y; Demirci G; Sayegh MH; Li XC
    J Immunol; 2004 Jul; 173(1):214-21. PubMed ID: 15210777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
    Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
    Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
    Front Immunol; 2019; 10():306. PubMed ID: 30863408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
    J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.